Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol dose comparison for bleeding during lumbar spine fusion surgery
IRCT20160307026950N30Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of labetalol in Bleeding (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Amount of bleeding during the operation. Started Jan 2021; status: completed.
02
Drugs
labetalol
03
Conditions
Bleeding
Beyond the preview
Go deeper on IRCT20160307026950N30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N30.